Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio

$2.69Billion– No. of Holdings #99

SUVRETTA CAPITAL MANAGEMENT, LLC Performance:
2024 Q1: 11.24%YTD: 11.24%2023: 16.65%

Performance for 2024 Q1 is 11.24%, and YTD is 11.24%, and 2023 is 16.65%.

About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in NEW YORK, NY. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.2 Billions. In it's latest 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $2.7 Billions as of 31 Mar, 2024.

The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are , KURA, ACLX. The fund has invested 8.1% of it's portfolio in BIOHAVEN LTD and 5.6% of portfolio in KURA ONCOLOGY INC.

The fund managers got completely rid off LAS VEGAS SANDS CORP (LVS), AGIOS PHARMACEUTICALS INC (AGIO) and ANAPTYSBIO INC (ANAB) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), TERNS PHARMACEUTICALS INC (TERN) and BOSTON SCIENTIFIC CORP (BSX). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in COCA COLA CO (KO), APPLE INC (AAPL) and CRH PLC (CRH). The fund showed a lot of confidence in some stocks as they added substantially to ALNYLAM PHARMACEUTICALS INC (ALNY), PEPGEN INC (PEPG) and ARGENX SE (ARGX).
SUVRETTA CAPITAL MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of 11.24% in the last quarter. In trailing 12 months, it's portfolio return was 31.02%.

New Buys

Ticker$ Bought
coca cola co33,434,900
apple inc30,297,100
crh plc28,947,100
arrivent biopharma inc27,927,800
fate therapeutics inc18,811,300
salesforce inc16,580,000
starbucks corp15,806,000
pinterest inc13,724,200

New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC

Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC

Reductions

Ticker% Reduced
cogent biosciences inc-91.48
terns pharmaceuticals inc-76.64
boston scientific corp-56.34
microsoft corp-51.02
mereo biopharma group plc-50.43
fulcrum therapeutics inc-48.39
teva pharmaceutical inds ltd-46.1
royalty pharma plc-42.12

SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker$ Sold
sana biotechnology inc-6,552,710
las vegas sands corp-36,325,000
agios pharmaceuticals inc-8,895,770
anaptysbio inc-7,601,360
astrazeneca plc-4,747,500
pfizer inc-1,448,140
incyte corp-2,360,900
merck & co inc-1,689,810

SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 52.3% of it's holdings in Healthcare sector.

Sector%
Healthcare52.3
Others20.5
Communication Services8
Technology7
Consumer Cyclical5.1
Industrials3.7
Financial Services2
Consumer Defensive1.4

Market Cap. Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 38.5% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP24.9
LARGE-CAP22.7
UNALLOCATED20.3
MEGA-CAP15.8
MID-CAP13.4
MICRO-CAP2.9

Stocks belong to which Index?

About 67.8% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200035
S&P 50032.8
Others32.2
Top 5 Winners (%)%
ARQT
arcutis biotherapeutics inc
205.5 %
AGLE
spyre therapeutics inc
76.3 %
BNTC
benitec biopharma inc
62.5 %
KURA
kura oncology inc
47.2 %
NTRA
natera inc
46.0 %
Top 5 Winners ($)$
ARQT
arcutis biotherapeutics inc
56.2 M
KURA
kura oncology inc
48.4 M
ACLX
arcellx inc
29.0 M
META
meta platforms inc
28.5 M
FULC
fulcrum therapeutics inc
14.8 M
Top 5 Losers (%)%
AKLI
akili inc
-40.5 %
MRNS
marinus pharmaceuticals inc
-16.5 %
RVNC
revance therapeutics inc
-13.1 %
INSM
insmed inc
-11.9 %
ALNY
alnylam pharmaceuticals inc
-11.0 %
Top 5 Losers ($)$
INSM
insmed inc
-9.9 M
MRNS
marinus pharmaceuticals inc
-9.6 M
EYPT
eyepoint pharmaceuticals inc
-8.2 M
KALV
kalvista pharmaceuticals inc
-3.3 M
ITCI
intra-cellular therapies inc
-3.0 M

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC

SUVRETTA CAPITAL MANAGEMENT, LLC has 99 stocks in it's portfolio. About 37.3% of the portfolio is in top 10 stocks. INSM proved to be the most loss making stock for the portfolio. ARQT was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions